Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival

Development

Volumn 122, Issue 8, 1996, Pages 2529-2537

  Vemuri, Geeta S ^a   McMorris, F Arthur ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Antioxidants; Apoptosis; Cell death; Cell survival; Growth factors; Oligodendrocytes; Phosphatidylinositol 3 kinase

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; BASIC FIBROBLAST GROWTH FACTOR; CILIARY NEUROTROPHIC FACTOR; DNA FRAGMENT; NEUROTROPHIN 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PROGESTERONE; SOMATOMEDIN C; WORTMANNIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; SERUM; SIGNAL TRANSDUCTION; STEM CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACETYLCYSTEINE; ANDROSTADIENES; APOPTOSIS; ASCORBIC ACID; BLOOD; CELL SURVIVAL; CHROMONES; CILIARY NEUROTROPHIC FACTOR; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; INSULIN-LIKE GROWTH FACTOR I; MORPHOLINES; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROTROPHIN 3; OLIGODENDROGLIA; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; STEM CELLS; VITAMIN E;

EID: 0029815526     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Arcaro, A. and Wymann, M. P. (1993). Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol (3,4,5)-trisphosphate in neutrophil responses. Biochem. J. 296, 297-301.
2. Barbacid, M. (1994). The trk family of neurotrophin receptors. J. Neurobiol. 25, 1386-1403.
3. Barres, B. A., Hart, I. K., Coles, H. S. R., Burne, J. F., Voyvodic, J. T., Richardson, W. D. and Raff, M. C. (1992). Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70, 31-46.
4. Barres, B. A., Schmid, R., Sendnter, M. and Raff, M. C. (1993). Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118, 283-295.
5. Bartlett, P. F., Noble, M. D., Pruss, R. M., Raff, M. C., Rattray, S. and Williams, C. A. (1981). Rat neural antigen-2 (RAN-2): a cell surface antigen on astrocytes, ependymal cells. Muller cells, and lepto-meninges defined by a monoclonal antibody. Brain Res. 204, 339-351.
6. Carson, M. J., Behringer, R. R., Brinster, R. L. and McMorris, F. A. (1993). Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10, 729-740.
7. Clarke, J. F., Young, P. W., Yonezawa, K., Kasuga, M. and Holman, G. D. (1994). Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-LI cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem. J. 300, 631-635.
8. Cross, M. J., Stewart, A., Hodgkin, M. N., Kerr, D. J. and Wakelam, M. J. O. (1995). Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase AT activity in Swiss 3T3 cells. J. Biol. Chem. 270, 25352-25355.
9. Eisenbarth, G. S., Walsh, F. S. and Nirenberg, M. (1979). Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. USA 76, 4913-4917.
10. Franke, T. F., Yang, S. I., Chan, T. O., Datta, K., Kazlauskas. A., Morrison, D. K. and Tsichlis, P. N. (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727-736.
11. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S. A. (1992). Identification of Programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119, 493-501.
12. Kapeller, R. and Cantley, L. C. (1994). Phosphatidylinositol 3-kinase. BioEssays 16, 565-576.
13. Kimura, K., Hattori, S., Kabuyama, Y., Shizawa, Y., Takayanagi, J., Nakamura, S., Toki, S., Matsuda, Y., Onodera, K. and Fukui, Y. (1994). Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidy linositol 3-kinase. J. Biol. Chem. 269, 18961-18967.
14. Kumagai, N., Morii, N., Fujisawa, K., Nemoto, Y. and Narumiya, S. (1993). ADP-ribosylation of rho p21 inhibits lysophosphatidic acid-induced protein (yrosine phosphory lation and phosphatidylinositol 3-kinase activation in cultured Swiss 3T3 cells. J. Biol Chem. 268, 24535-24538.
15. Labarca, C. and Paigen, K. (1980). A simple, rapid, and sensitive DNA assay procedure. Analyt. Biochem. 102, 344-352.
16. Louis, J. C., Magal, E., Takayama, S. and Varon, S. (1993). CNTF protection of oligodendrocytes against natural and tumor necrosis factorinduced death. Science 259, 689-692.
17. Malarkey, K., Belham, C. M., Paul, A., Graham, A., McLees, A., Scott, P. H. and Plevin, R. (1995). The regulation of tyrosine kinase signalling pathways by growth factor and G-protein coupled receptors. Biochem. J. 390, 361-375.
18. Mayer, M. and Noble, M. (1994). N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc. Natl. Acad. Sci. USA 91, 7496-7500.
19. McCarthy, K. D. and de Vellis, J. (1980). Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Binl. 85, 890-902.
20. McMorris, F. A., Smith, T. M., DeSalvo, S. and Furlanetto, R. W. (1986). Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development. Prnc. Natl. Acad. Sci. USA 83, 822-826.
21. McMorris, F. A. and Dubois-Dalcq, M. (1988). Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J. Neurosci. Res. 21, 199-209.
22. McMorris, F. A., Furlanetto, R. W., Mozell, R. L., Carson, M. J. and Raible, D. W. (1990). Regulation of oligodendrocyte development by insulin-like growth factors and cyclic AMP. In Cellular and Molecular Biology of Myelination (eds. G. Jeserich, H. H. Althaus and T. V. Waehneldt), pp. 281-292. Berlin: Springer-Verlag.
23. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
24. Nakanishi, H., Brewer, K. A. and Exton, J. H. (1993). Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 268, 13-16.
25. Oka, A., Belliveau, M. J., Rosenberg, P. A. and Volpe, J. J. (1993). Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms and prevention. J. Neurosci. 13, 1441-1453.
26. Raff, M. C. (1992). Social controls on cell survival and cell death. Nature 356, 397-400.
27. Raible, D. W. and McMorris, F. A. (1989). Cyclic AMP regulates the rate of differentiation of oligodendrocytes without changing the lineage commitment of their progenitors. Dev. Biol 133, 437-446.
28. Raible, D. W. and McMorris, F. A. (1990). Induction of oligodendrocyte differentiation by activators of adenylate cyclase. J. Neurosci. Res. 27, 43-46.
29. Richardson, W. D., Pringle, N., Mosley, M. J., Westermark, B. and DuboisDalcq, M. (1988). A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53, 309-319.
30. Selmaj, K., Raine C. S., Farooq, M., Norton, W. T. and Brosnan, C. F. (1991). Cytokine cytotoxicity against oligodendrocytes. J. Immunol. 147, 1522-1529.
31. Sommer, I. and Schachner, M. (1981). Monoclonal antibodies (0l to 04) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev. Biol. 83, 311-327.
32. Stahl, N. and Yancopoulos, G. D. (1994). The tripartite CNTF receptor complex: activation and signaling involves components shared with other cytokines. J. Nearobiol. 25, 1454-1466.
33. Stephens, L., Smrcka, A., Cooke, F. T., Jackson, T. R., Sternweis, P. C. and Hawkins, P. T. (1994). A novel phosphoinositide 3-kinase activity in myeloid-derived cells activated by G protein βγsubunits. Cell 77, 83-93.
34. 3. J. Biol. Chem. 269, 32358-32367.
35. Ui, M., Okada, T., Hazeki, K. and Hazeki, O. (1995). Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem. Sci. 20, 303-307.
36. Vainikka, S., Joukov, V., Wennstrom, S., Bergman, M., Pelicci, P. G. and Alitalo, K. (1994). Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. J. Biol. Chem. 269, 18320-18326.
37. Vemuri, G. S. and Rittenhouse, S. E. (1994). Wortmannin inhibits seruminduced activation of phosphoinositide 3-kinase and proliferation of CHRF-288 cells. Biochem. Biophys. Res. Commun. 202, 1619-1623.
38. Vlahos, C. J., Matter, W. F., Hui, K. Y. and Brown, R. F. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-l-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241-5248.
39. White, M. F. and Kahn, C. R. (1994). The insulin signaling system. J. Biol. Chem. 269, 1-4.
40. Yano, H., Nakanishi, S., Kimura, K., Hanai, N., Saitoh, Y., Fukui, Y., Nonomura, Y. and Matsuda, Y. (1993). Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268, 25846-25856.
41. Yao, R. and Cooper, G. M. (1995). Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006.
42. Yasuda, T., Grinspan, J., Stern, J., Franceschini, B., Bannerman. P. and Pleasure, D. (1995). Apoptosis occurs in the oligodendroglial lineage, and is prevented by basic fibroblast growth factor. J. Neurosci. Res. 40, 306-317.